Epithelioid sarcoma

One institution's experience with a rare sarcoma

Angela A. Guzzetta, Elizabeth A. Montgomery, Heather Lyu, Craig M. Hooker, Christian F. Meyer, David M. Loeb, Deborah Frassica, Kristy L. Weber, Nita Ahuja

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Background: Epithelioid sarcomas (ES) are extremely rare soft tissue sarcomas. As such, their clinical behavior and response to treatment are poorly described in the literature. Methods: We queried the centralized cancer registry and pathology archives at the Johns Hopkins Medical Institution and identified 22 patients with a diagnosis of ES. We excluded two patients because of inadequate data. A pathologist reviewed patient charts and reexamined available histological slides. This study was performed with institutional review board approval. Results: The median age at diagnosis was 27.8 y; most patients (75%) were male. Regional lymph node metastases were present in 10% of patients at presentation. The majority of tumors (57.9%) recurred and 35% recurred more than once, although the number of recurrences did not affect survival (P = 0.48). Patients did not experience a decrease in time to recurrence with increasing number of resections. The median time between resection and recurrence was 1.23 y and the maximum was 18.8 y. Median overall survival was 56.2 mo and 5-y survival was 92%. Conclusions: Our study reveals that ES is an extremely rare tumor with a protracted and recurrent course, but overall survival may be more favorable than in the past. Patients benefit from aggressive and repeated resection. Epithelioid sarcoma is unique because it metastasizes to regional nodal basins. Extended surveillance is indicated, because recurrences can appear after decades of quiescence.

Original languageEnglish (US)
Pages (from-to)116-122
Number of pages7
JournalJournal of Surgical Research
Volume177
Issue number1
DOIs
StatePublished - Sep 1 2012
Externally publishedYes

Fingerprint

Sarcoma
Recurrence
Survival
Neoplasms
Research Ethics Committees
Registries
Lymph Nodes
Pathology
Neoplasm Metastasis

Keywords

  • Epithelioid sarcoma
  • Lymph node metastasis
  • Outcomes
  • Proximal-type sarcoma
  • Rhabdoid epithelioid sarcoma
  • Sarcoma

ASJC Scopus subject areas

  • Surgery

Cite this

Guzzetta, A. A., Montgomery, E. A., Lyu, H., Hooker, C. M., Meyer, C. F., Loeb, D. M., ... Ahuja, N. (2012). Epithelioid sarcoma: One institution's experience with a rare sarcoma. Journal of Surgical Research, 177(1), 116-122. https://doi.org/10.1016/j.jss.2012.04.030

Epithelioid sarcoma : One institution's experience with a rare sarcoma. / Guzzetta, Angela A.; Montgomery, Elizabeth A.; Lyu, Heather; Hooker, Craig M.; Meyer, Christian F.; Loeb, David M.; Frassica, Deborah; Weber, Kristy L.; Ahuja, Nita.

In: Journal of Surgical Research, Vol. 177, No. 1, 01.09.2012, p. 116-122.

Research output: Contribution to journalArticle

Guzzetta, AA, Montgomery, EA, Lyu, H, Hooker, CM, Meyer, CF, Loeb, DM, Frassica, D, Weber, KL & Ahuja, N 2012, 'Epithelioid sarcoma: One institution's experience with a rare sarcoma', Journal of Surgical Research, vol. 177, no. 1, pp. 116-122. https://doi.org/10.1016/j.jss.2012.04.030
Guzzetta, Angela A. ; Montgomery, Elizabeth A. ; Lyu, Heather ; Hooker, Craig M. ; Meyer, Christian F. ; Loeb, David M. ; Frassica, Deborah ; Weber, Kristy L. ; Ahuja, Nita. / Epithelioid sarcoma : One institution's experience with a rare sarcoma. In: Journal of Surgical Research. 2012 ; Vol. 177, No. 1. pp. 116-122.
@article{afaf2605fe194325bdaa407fdde0a1a2,
title = "Epithelioid sarcoma: One institution's experience with a rare sarcoma",
abstract = "Background: Epithelioid sarcomas (ES) are extremely rare soft tissue sarcomas. As such, their clinical behavior and response to treatment are poorly described in the literature. Methods: We queried the centralized cancer registry and pathology archives at the Johns Hopkins Medical Institution and identified 22 patients with a diagnosis of ES. We excluded two patients because of inadequate data. A pathologist reviewed patient charts and reexamined available histological slides. This study was performed with institutional review board approval. Results: The median age at diagnosis was 27.8 y; most patients (75{\%}) were male. Regional lymph node metastases were present in 10{\%} of patients at presentation. The majority of tumors (57.9{\%}) recurred and 35{\%} recurred more than once, although the number of recurrences did not affect survival (P = 0.48). Patients did not experience a decrease in time to recurrence with increasing number of resections. The median time between resection and recurrence was 1.23 y and the maximum was 18.8 y. Median overall survival was 56.2 mo and 5-y survival was 92{\%}. Conclusions: Our study reveals that ES is an extremely rare tumor with a protracted and recurrent course, but overall survival may be more favorable than in the past. Patients benefit from aggressive and repeated resection. Epithelioid sarcoma is unique because it metastasizes to regional nodal basins. Extended surveillance is indicated, because recurrences can appear after decades of quiescence.",
keywords = "Epithelioid sarcoma, Lymph node metastasis, Outcomes, Proximal-type sarcoma, Rhabdoid epithelioid sarcoma, Sarcoma",
author = "Guzzetta, {Angela A.} and Montgomery, {Elizabeth A.} and Heather Lyu and Hooker, {Craig M.} and Meyer, {Christian F.} and Loeb, {David M.} and Deborah Frassica and Weber, {Kristy L.} and Nita Ahuja",
year = "2012",
month = "9",
day = "1",
doi = "10.1016/j.jss.2012.04.030",
language = "English (US)",
volume = "177",
pages = "116--122",
journal = "Journal of Surgical Research",
issn = "0022-4804",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - Epithelioid sarcoma

T2 - One institution's experience with a rare sarcoma

AU - Guzzetta, Angela A.

AU - Montgomery, Elizabeth A.

AU - Lyu, Heather

AU - Hooker, Craig M.

AU - Meyer, Christian F.

AU - Loeb, David M.

AU - Frassica, Deborah

AU - Weber, Kristy L.

AU - Ahuja, Nita

PY - 2012/9/1

Y1 - 2012/9/1

N2 - Background: Epithelioid sarcomas (ES) are extremely rare soft tissue sarcomas. As such, their clinical behavior and response to treatment are poorly described in the literature. Methods: We queried the centralized cancer registry and pathology archives at the Johns Hopkins Medical Institution and identified 22 patients with a diagnosis of ES. We excluded two patients because of inadequate data. A pathologist reviewed patient charts and reexamined available histological slides. This study was performed with institutional review board approval. Results: The median age at diagnosis was 27.8 y; most patients (75%) were male. Regional lymph node metastases were present in 10% of patients at presentation. The majority of tumors (57.9%) recurred and 35% recurred more than once, although the number of recurrences did not affect survival (P = 0.48). Patients did not experience a decrease in time to recurrence with increasing number of resections. The median time between resection and recurrence was 1.23 y and the maximum was 18.8 y. Median overall survival was 56.2 mo and 5-y survival was 92%. Conclusions: Our study reveals that ES is an extremely rare tumor with a protracted and recurrent course, but overall survival may be more favorable than in the past. Patients benefit from aggressive and repeated resection. Epithelioid sarcoma is unique because it metastasizes to regional nodal basins. Extended surveillance is indicated, because recurrences can appear after decades of quiescence.

AB - Background: Epithelioid sarcomas (ES) are extremely rare soft tissue sarcomas. As such, their clinical behavior and response to treatment are poorly described in the literature. Methods: We queried the centralized cancer registry and pathology archives at the Johns Hopkins Medical Institution and identified 22 patients with a diagnosis of ES. We excluded two patients because of inadequate data. A pathologist reviewed patient charts and reexamined available histological slides. This study was performed with institutional review board approval. Results: The median age at diagnosis was 27.8 y; most patients (75%) were male. Regional lymph node metastases were present in 10% of patients at presentation. The majority of tumors (57.9%) recurred and 35% recurred more than once, although the number of recurrences did not affect survival (P = 0.48). Patients did not experience a decrease in time to recurrence with increasing number of resections. The median time between resection and recurrence was 1.23 y and the maximum was 18.8 y. Median overall survival was 56.2 mo and 5-y survival was 92%. Conclusions: Our study reveals that ES is an extremely rare tumor with a protracted and recurrent course, but overall survival may be more favorable than in the past. Patients benefit from aggressive and repeated resection. Epithelioid sarcoma is unique because it metastasizes to regional nodal basins. Extended surveillance is indicated, because recurrences can appear after decades of quiescence.

KW - Epithelioid sarcoma

KW - Lymph node metastasis

KW - Outcomes

KW - Proximal-type sarcoma

KW - Rhabdoid epithelioid sarcoma

KW - Sarcoma

UR - http://www.scopus.com/inward/record.url?scp=84865073790&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84865073790&partnerID=8YFLogxK

U2 - 10.1016/j.jss.2012.04.030

DO - 10.1016/j.jss.2012.04.030

M3 - Article

VL - 177

SP - 116

EP - 122

JO - Journal of Surgical Research

JF - Journal of Surgical Research

SN - 0022-4804

IS - 1

ER -